A Study to Evaluate the Safety and Antitumor Activity of GS-1206 in Adults With Solid Tumors
NCT07703878
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
302
Enrollment
INDUSTRY
Sponsor class
Conditions
Solid Tumor
Interventions
DRUG:
GS-1206
Sponsor
Gilead Sciences